207 related articles for article (PubMed ID: 33548449)
1. The Benefit of Atrioventricular Junction Ablation for Permanent Atrial Fibrillation and Heart Failure Patients Receiving Cardiac Resynchronization Therapy: An Updated Systematic Review and Meta-analysis.
Waranugraha Y; Rizal A; Setiawan D; Aziz IJ
Indian Pacing Electrophysiol J; 2021; 21(2):101-111. PubMed ID: 33548449
[TBL] [Abstract][Full Text] [Related]
2. Clinical Outcomes After Ablation of the AV Junction in Patients With Atrial Fibrillation: Impact of Cardiac Resynchronization Therapy.
Mittal S; Musat DL; Hoskins MH; Prillinger JB; Roberts GJ; Nabutovsky Y; Merchant FM
J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29180458
[TBL] [Abstract][Full Text] [Related]
3. Comparison of survival for cardiac resynchronization therapy in atrial fibrillation patients with or without atrio-ventricular junction ablation and patients in sinus rhythm: a systematic review and network meta-analysis.
Xue Y; Wang J; Wang J; Thapa S; Huang K; Peng Y; Qian L; Li J; Ji K
Heart Fail Rev; 2019 May; 24(3):335-342. PubMed ID: 30610455
[TBL] [Abstract][Full Text] [Related]
4. Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry).
Gasparini M; Leclercq C; Lunati M; Landolina M; Auricchio A; Santini M; Boriani G; Lamp B; Proclemer A; Curnis A; Klersy C; Leyva F
JACC Heart Fail; 2013 Dec; 1(6):500-7. PubMed ID: 24622002
[TBL] [Abstract][Full Text] [Related]
5. Impact of atrioventricular junction ablation and CRT-D on long-term mortality in patients with left ventricular dysfunction, permanent, refractory atrial fibrillation, and narrow QRS: Results of a propensity-matched analysis.
Palmisano P; Ziacchi M; Ammendola E; Dell'Era G; Guerra F; Donateo P; Del Giorno G; Laffi M; Coluccia G; Bartoli L; Gaggioli G; Carbone A; Senes J; Dello Russo A; Patti G; Nigro G; Biffi M; Accogli M
J Cardiovasc Electrophysiol; 2022 Nov; 33(11):2288-2296. PubMed ID: 35930617
[TBL] [Abstract][Full Text] [Related]
6. Atrioventricular junction ablation in patients with atrial fibrillation treated with cardiac resynchronization therapy: positive impact on ventricular arrhythmias, implantable cardioverter-defibrillator therapies and hospitalizations.
Gasparini M; Kloppe A; Lunati M; Anselme F; Landolina M; Martinez-Ferrer JB; Proclemer A; Morani G; Biffi M; Ricci R; Rordorf R; Mangoni L; Manotta L; Grammatico A; Leyva F; Boriani G
Eur J Heart Fail; 2018 Oct; 20(10):1472-1481. PubMed ID: 29251799
[TBL] [Abstract][Full Text] [Related]
7. A conversion CRT strategy combined with AVJA may be a perspective alternative for heart failure patients with persistent atrial fibrillation.
Chen M; Dong Z; Zhang Y; Liu J; Zhang J
Heart Fail Rev; 2023 Mar; 28(2):367-377. PubMed ID: 36662339
[TBL] [Abstract][Full Text] [Related]
8. Effects of atrioventricular nodal ablation on permanent atrial fibrillation patients with cardiac resynchronization therapy: a systematic review and meta-analysis.
Yin J; Hu H; Wang Y; Xue M; Li X; Cheng W; Li X; Yan S
Clin Cardiol; 2014 Nov; 37(11):707-15. PubMed ID: 25156448
[TBL] [Abstract][Full Text] [Related]
9. Junctional AV ablation in patients with atrial fibrillation undergoing cardiac resynchronization therapy (JAVA-CRT): results of a multicenter randomized clinical trial pilot program.
Steinberg JS; Gorcsan J; Mazur A; Jain SK; Rashtian M; Greer GS; Zarraga I; Vloka M; Cook MM; Salam T; Mountantonakis S; Beck H; Silver J; Aktas M; Henrikson C; Schaller RD; Epstein AE; McNitt S; Schleede S; Peterson D; Goldenberg I; Zareba W
J Interv Card Electrophysiol; 2022 Aug; 64(2):519-530. PubMed ID: 35043250
[TBL] [Abstract][Full Text] [Related]
10. Outcomes after atrioventricular node ablation and biventricular pacing in patients with refractory atrial fibrillation and heart failure: a comparison between non-ischaemic and ischaemic cardiomyopathy.
Sohinki D; Ho J; Srinivasan N; Collins LJ; Obel OA
Europace; 2014 Jun; 16(6):880-6. PubMed ID: 24525552
[TBL] [Abstract][Full Text] [Related]
11. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.
Gasparini M; Auricchio A; Regoli F; Fantoni C; Kawabata M; Galimberti P; Pini D; Ceriotti C; Gronda E; Klersy C; Fratini S; Klein HH
J Am Coll Cardiol; 2006 Aug; 48(4):734-43. PubMed ID: 16904542
[TBL] [Abstract][Full Text] [Related]
12. Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis.
Stavrakis S; Garabelli P; Reynolds DW
Europace; 2012 Oct; 14(10):1490-7. PubMed ID: 22696519
[TBL] [Abstract][Full Text] [Related]
13. Atrioventricular nodal ablation predicts survival benefit in patients with atrial fibrillation receiving cardiac resynchronization therapy.
Dong K; Shen WK; Powell BD; Dong YX; Rea RF; Friedman PA; Hodge DO; Wiste HJ; Webster T; Hayes DL; Cha YM
Heart Rhythm; 2010 Sep; 7(9):1240-5. PubMed ID: 20156595
[TBL] [Abstract][Full Text] [Related]
14. Does permanent atrial fibrillation modify response to cardiac resynchronization therapy in heart failure patients?
Abreu A; Oliveira M; Silva Cunha P; Santa Clara H; Portugal G; Gonçalves Rodrigues I; Santos V; Morais L; Selas M; Soares R; Branco L; Ferreira R; Mota Carmo M;
Rev Port Cardiol; 2017 Oct; 36(10):687-694. PubMed ID: 29031455
[TBL] [Abstract][Full Text] [Related]
15. Assessment of upgrading to biventricular pacing in patients with right ventricular pacing and congestive heart failure after atrioventricular junctional ablation for chronic atrial fibrillation.
Valls-Bertault V; Fatemi M; Gilard M; Pennec PY; Etienne Y; Blanc JJ
Europace; 2004 Sep; 6(5):438-43. PubMed ID: 15294269
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS.
Brignole M; Pokushalov E; Pentimalli F; Palmisano P; Chieffo E; Occhetta E; Quartieri F; Calò L; Ungar A; Mont L;
Eur Heart J; 2018 Dec; 39(45):3999-4008. PubMed ID: 30165479
[TBL] [Abstract][Full Text] [Related]
17. Role of Atrio-Ventricular Junction Ablation in Symptomatic Atrial Fibrillation for Optimization of Cardiac Resynchronization Therapy.
Garabelli PJ; Stavrakis S
J Atr Fibrillation; 2013; 5(6):787. PubMed ID: 28496831
[TBL] [Abstract][Full Text] [Related]
18. A strategy to achieve CRT response in permanent atrial fibrillation without obligatory atrioventricular node ablation.
Himmel F; Reppel M; Mortensen K; Schunkert H; Bode F
Pacing Clin Electrophysiol; 2012 Aug; 35(8):943-7. PubMed ID: 22650352
[TBL] [Abstract][Full Text] [Related]
19. Pacemaker and Atrioventricular Junction Ablation in Patients With Atrial Fibrillation-A Systematic Review of Systematic Review and Meta-Analysis.
Zhang C; Wang XY; Lou L; Zhang X; Chen LL; Chen YX; Yang J
Front Cardiovasc Med; 2021; 8():587297. PubMed ID: 35127840
[TBL] [Abstract][Full Text] [Related]
20. AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
Brignole M; Pentimalli F; Palmisano P; Landolina M; Quartieri F; Occhetta E; Calò L; Mascia G; Mont L; Vernooy K; van Dijk V; Allaart C; Fauchier L; Gasparini M; Parati G; Soranna D; Rienstra M; Van Gelder IC;
Eur Heart J; 2021 Dec; 42(46):4731-4739. PubMed ID: 34453840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
